Specialized psychosocial interventions—including meaning-centered psychotherapy—can greatly improve a cancer patient's quality of life and reduce suffering.
Cancer patients on active treatment are 35% less likely to develop COVID-19 than patients not receiving treatment, though those who did test positive for SARS-CoV-2 experienced higher death rates.
Cancer immunotherapy drugs only work for a minority of patients, but a generic drug now used to increase blood flow may be able to improve those odds, a study by Columbia University Medical Center researchers suggests.
Immunotherapy expert Pawel Muranski speaks about the new CAR-T therapy for leukemia and his work to bring T cell therapies to patients with a wide range of cancers.
Velocity is a new cycling event that benefits the Herbert Irving Comprehensive Cancer Center at CUIMC. Columbia riders share why they joined the cause.
Researchers discovered a mechanism that reprograms tumor cells in patients with advanced prostate cancer, reducing their response to anti-androgen therapy.
Based on new evidence, laparoscopic surgery should be offered to most women with early-stage endometrial cancer, says Columbia’s gynecologic cancer chief.